DKSH Holding AG
SIX:DKSH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
DKSH Holding AG
SIX:DKSH
|
CH |
|
B
|
B.P. Marsh & Partners PLC
XBER:B5V
|
UK |
|
Indian Hotels Company Ltd
BSE:500850
|
IN |
|
Biogen Inc
NASDAQ:BIIB
|
US |
|
United Utilities Group PLC
OTC:UUGRY
|
UK |
|
T
|
Teleflex Inc
F:TBH
|
US |
|
T
|
Terracom Ltd
OTC:TERCF
|
AU |
|
Pila Pharma AB
F:5KC
|
SE |
|
Mitsui Chemicals Inc
F:MSI
|
JP |
|
Noritake Co Ltd
TSE:5331
|
JP |
|
MCJ Co Ltd
TSE:6670
|
JP |
|
M
|
Mitsubishi UFJ Financial Group Inc
OTC:MBFJF
|
JP |
DKSH Holding AG
DKSH Holding AG helps consumer brands, health companies, and industrial suppliers sell into Asian markets. It does not mainly make products itself; instead, it acts as a sales, marketing, distribution, and logistics partner. The company connects foreign brands with local customers, handles warehousing and transport, and often manages field sales, retail promotion, and after-sales support. Its customers are mostly companies that want a local partner in Asia, along with businesses that need specialty materials or healthcare products delivered through a reliable regional network. DKSH makes money by charging fees for market expansion services and by earning trading and distribution margins when it buys and resells products. That mix gives it both a service business and a physical supply chain business. What makes DKSH different is its role as an on-the-ground market entry and distribution specialist. For many international companies, especially in harder-to-navigate Asian markets, DKSH is the local engine that moves products from manufacturer to end customer. That makes it an important middle link between global suppliers and local buyers.
DKSH Holding AG helps consumer brands, health companies, and industrial suppliers sell into Asian markets. It does not mainly make products itself; instead, it acts as a sales, marketing, distribution, and logistics partner. The company connects foreign brands with local customers, handles warehousing and transport, and often manages field sales, retail promotion, and after-sales support.
Its customers are mostly companies that want a local partner in Asia, along with businesses that need specialty materials or healthcare products delivered through a reliable regional network. DKSH makes money by charging fees for market expansion services and by earning trading and distribution margins when it buys and resells products. That mix gives it both a service business and a physical supply chain business.
What makes DKSH different is its role as an on-the-ground market entry and distribution specialist. For many international companies, especially in harder-to-navigate Asian markets, DKSH is the local engine that moves products from manufacturer to end customer. That makes it an important middle link between global suppliers and local buyers.
Revenue: DKSH said first-half net sales rose 4.9% to CHF 5.5 billion, its strongest first-half growth in 3 years, with growth broad-based across all 4 business units.
Profitability: Core EBIT increased 3.6% to CHF 163.4 million, but margin slipped to 3.0% as foreign exchange, healthcare ramp-up costs, and consumer marketing spending weighed on profitability.
Cash: Free cash flow stayed strong at CHF 147.7 million and cash conversion was 130.8%, well above the company’s target for a fourth straight year.
Outlook: Management reconfirmed its midterm roadmap and said Core EBIT in 2026 should be higher than in 2025, with a stronger second half expected.
Growth drivers: Healthcare business development, data center demand in Technology, and M&A were highlighted as key second-half drivers, while DKSH said it has already announced or completed acquisitions that should add about 1 percentage point to 2026 net sales growth.
AI push: The company said it is expanding AI use across sales, operations, legal, and fulfillment, but these investments temporarily weighed on margins and are expected to support future growth and productivity.
